Peptide to sell division to Medivir

Peptide (LSE:PTE) plans to sell its Mimetrix drug discovery business to Medivir (SSE:MVIR) for up to 6 million ($9.6 million). PTE will receive 2 million worth of MVIR shares, and up to an additional ...